Form4insider filings, from the source

SEC Form 4 · accession 0001077183-19-000037

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Douglas M Van Oort
Officer — Chairman and CEO · Director
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 1, 2019A37,883$0.00A2,092,435D
Common StockF1holding———187,500IConundrum Capital Partners

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$19.60Mar 1, 2019A231,567AMar 1, 2020Mar 1, 2024Common Stock231,567231,567D
Stock Option (Right to Buy)F3$7.52holding———Apr 28, 2018Apr 28, 2022Common Stock500,000500,000D
Stock Option (Right to Buy)F4$8.03holding———Feb 26, 2019Feb 26, 2023Common Stock500,000500,000D
Stock Option (Right to Buy)F5$7.15holding———Apr 20, 2017Apr 20, 2021Common Stock472,527472,527D

Explanation of responses